Cochrane Abstracts
Role of chemotherapy additional to high‐dose methotrexate for primary central nervous system lymphoma (PCNSL)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Role of Chemotherapy Additional to High‐dose Methotrexate for Primary Central Nervous System Lymphoma (PCNSL)." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434779/all/Role_of_chemotherapy_additional_to_high‐dose_methotrexate_for_primary_central_nervous_system_lymphoma__PCNSL_.
Role of chemotherapy additional to high‐dose methotrexate for primary central nervous system lymphoma (PCNSL). Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434779/all/Role_of_chemotherapy_additional_to_high‐dose_methotrexate_for_primary_central_nervous_system_lymphoma__PCNSL_. Accessed January 24, 2026.
Role of chemotherapy additional to high‐dose methotrexate for primary central nervous system lymphoma (PCNSL). (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434779/all/Role_of_chemotherapy_additional_to_high‐dose_methotrexate_for_primary_central_nervous_system_lymphoma__PCNSL_
Role of Chemotherapy Additional to High‐dose Methotrexate for Primary Central Nervous System Lymphoma (PCNSL) [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434779/all/Role_of_chemotherapy_additional_to_high‐dose_methotrexate_for_primary_central_nervous_system_lymphoma__PCNSL_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Role of chemotherapy additional to high‐dose methotrexate for primary central nervous system lymphoma (PCNSL)
ID - 434779
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434779/all/Role_of_chemotherapy_additional_to_high‐dose_methotrexate_for_primary_central_nervous_system_lymphoma__PCNSL_
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
